GTS Securities Slashes Its XOVR Stake -- Selling $354 Million Worth of Shares
Yahoo Finance ·
According to a recent SEC filing , GTS Securities sold 19,462,657 shares of the ERShares Private-Public Crossover ETF ( XOVR +0.13% ) during the first quarter. The estimated transaction value was approximately $354.2 million, calculated using the quarter’s average closing price. The fund's quarter-end position value in XOVR declined by $392.2 million, reflecting both the share sale and price movement over the period. GTS Securities' XOVR stake now represents just 0.03% of its 13F-reportable AUM, down from 13.4% in the previous quarter. After the sale, GTS Securities' top five reported holdings were: NASDAQ: QQQ: $140.4 million (5.0% of AUM) NASDAQ: NVDA: $80.4 million (2.8% of AUM) NASDAQ: MSFT: $69.5 million (2.5% of AUM) As of May 25, 2026, XOVR shares were trading at $19.53, up about 10.5% over the past year, trailing the S&P 500 by roughly 17.5 percentage points, and underperforming its Large Growth category benchmark by roughly 18.6 percentage points over the same period. The ERShares Private-Public Crossover ETF (XOVR) is designed to give everyday investors access to both publicly traded growth companies and a curated sleeve of private company holdings -- all within a single fund. The fund blends exposure to public innovators with a measured allocation to private companies, aiming to bridge the gap between public and private markets in a transparent, accessible format. Structured as an ETF for daily liquidity. At first glance, a single institution offloading $354 million worth of an ETF sounds alarming -- but context is always important. GTS Securities is a high-frequency trading and market-making firm, not a traditional asset manager. Firms like GTS routinely carry large ETF positions as part of their liquidity-provision and arbitrage operations, and those positions can shift dramatically from one quarter to the next for reasons unrelated to the ETF's fundamental merits. That said, XOVR's relative performance is worth noting. The ETF's roughly 10.5% gain over the past year looks modest compared with the broader market -- a nearly 18-percentage-point gap vs. the S&P 500. And investors aren't receiving any income while they wait for the growth thesis to play out: XOVR pays no dividend, and its 0.75% annual expense ratio isn’t exactly cheap. The core concept here is genuinely interesting -- XOVR attempts to give everyday investors a slice of private-market growth that would otherwise be inaccessible, wrapped in an ETF. It's also worth noting that SpaceX (private) is a dominant piece of XOVR’s portfolio at approximately 23% of the fund -- a meaningful draw for anyone looking for exposure to one of the most closely watched private companies in the world. For investors specifically seeking this type of private-market exposure, XOVR could make sense as a small satellite position. But for a typical buy-and-hold investor focused on long-term, diversified growth, the combination of lagging returns, a relatively high expense ratio, and zero income makes the case harder to justify as a core holding. For most retail investors, the GTS sale is unlikely to signal a fundamental problem with XOVR. It's more of a reminder that institutional 13F filings can look dramatic in size while reflecting routine trading activity rather than a change in conviction. Investors curious about private-public crossover strategies may want to evaluate XOVR's holdings, fee structure, and longer-term track record before drawing any conclusions from this filing alone.
AI 시장 분석
GTS Securities sold $354 million worth of its XOVR ETF stake in Q1, interpreted as part of routine market-making activities. XOVR, an ETF bridging private and public markets including SpaceX, has significantly underperformed the S&P 500.
상승 영향
- Large-Cap Growth Technology (QQQ, NVDA, — GTS Securities maintains significant holdings in large-cap growth stocks like QQQ, NVDA, and MSFT after the XOVR sale, indicating continued institutional preference for these sectors.
하락 영향
- Private-Public Crossover ETFs (XOVR) — XOVR's underperformance against the S&P 500, high expense ratio, and lack of dividends make it less attractive for general investors.
- Private Market Exposure Products — XOVR's lagging performance may foster skepticism among investors regarding similar ETF products designed to provide access to private markets.
AI가 생성한 분석으로 투자 자문이 아닙니다.
DYAX Investor Sentiment
Bullish (Long) 34% · Bearish (Short) 66%
440 participants
Related News
- Amazon, Alphabet, and Microsoft: 2 Cloud Giants I Am Buying in September and 1 I Am Avoiding
- Merck (MRK) announces that the US FDA has approved an update to the US product label for WINREVAIR for injection, 45mg, 60mg, based on the Phase 3 HYPERION trial.
- SanDisk Stock Projected Near Low $2,000s by 2030, Potentially Lagging Market Returns
- Meta's Muse Claims Top iOS Spot as Markets Price In Agentic Shift
- Can Shiba Inu Reach $1 in the Upcoming Crypto Bull Market?
- Global Market and Corporate News Briefing